Endurant Capital Management LP - Q4 2014 holdings

$255 Million is the total value of Endurant Capital Management LP's 87 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was - .

 Value Shares↓ Weighting
TMO NewTHERMO FISHER SCIENTIFIC INC$15,154,000120,950
+100.0%
5.95%
BDX NewBECTON DICKINSON & CO$12,421,00089,260
+100.0%
4.87%
B108PS NewACTAVIS PLC$10,231,00039,747
+100.0%
4.01%
UHS NewUNIVERSAL HLTH SVCS INCcl b$9,532,00085,675
+100.0%
3.74%
ANTM NewANTHEM INC$9,191,00073,135
+100.0%
3.61%
CYH NewCOMMUNITY HEALTH SYS INC NEW$9,126,000169,250
+100.0%
3.58%
HLS NewHEALTHSOUTH CORP$9,066,000235,738
+100.0%
3.56%
LH NewLABORATORY CORP AMER HLDGS$7,843,00072,692
+100.0%
3.08%
TEVA NewTEVA PHARMACEUTICAL INDS LTDadr$7,643,000132,900
+100.0%
3.00%
MDT NewMEDTRONIC INC$7,523,000104,200
+100.0%
2.95%
MCK NewMCKESSON CORP$6,879,00033,140
+100.0%
2.70%
NVS NewNOVARTIS A Gsponsored adr$6,597,00071,200
+100.0%
2.59%
HOLX NewHOLOGIC INC$6,111,000228,540
+100.0%
2.40%
CAH NewCARDINAL HEALTH INC$5,877,00072,800
+100.0%
2.31%
DGX NewQUEST DIAGNOSTICS INC$5,566,00083,000
+100.0%
2.18%
GMED NewGLOBUS MED INCcl a$4,999,000210,300
+100.0%
1.96%
EVHC NewENVISION HEALTHCARE HLDGS IN$4,090,000117,910
+100.0%
1.60%
5100PS NewVOLCANO CORPORATION$3,976,000222,350
+100.0%
1.56%
BCR NewBARD C R INC$3,949,00023,699
+100.0%
1.55%
AGN NewALLERGAN INC$3,795,00017,850
+100.0%
1.49%
MDRX NewALLSCRIPTS HEALTHCARE SOLUTN$3,690,000288,950
+100.0%
1.45%
UNH NewUNITEDHEALTH GROUP INC$3,649,00036,100
+100.0%
1.43%
BIIB NewBIOGEN IDEC INC$3,263,0009,612
+100.0%
1.28%
MYL NewMYLAN INC$3,151,00055,900
+100.0%
1.24%
MNKKQ NewMALLINCKRODT PUB LTD CO$2,982,00030,109
+100.0%
1.17%
STJ NewST JUDE MED INC$2,974,00045,731
+100.0%
1.17%
F113PS NewCOVIDIEN PLC$2,941,00028,750
+100.0%
1.15%
ASPX NewAUSPEX PHARMACEUTICALS INC$2,831,00053,950
+100.0%
1.11%
BSX NewBOSTON SCIENTIFIC CORP$2,826,000213,300
+100.0%
1.11%
VRX NewVALEANT PHARMACEUTICALS INTL$2,748,00019,200
+100.0%
1.08%
QSII NewQUALITY SYS INC$2,631,000168,750
+100.0%
1.03%
A NewAGILENT TECHNOLOGIES INC$2,582,00063,065
+100.0%
1.01%
PKI NewPERKINELMER INC$2,536,00058,000
+100.0%
1.00%
AMSG NewAMSURG CORP$2,419,00044,200
+100.0%
0.95%
OCR NewOMNICARE INC$2,410,00033,045
+100.0%
0.95%
DVA NewDAVITA HEALTHCARE PARTNERS I$2,405,00031,747
+100.0%
0.94%
MRK NewMERCK & CO INC NEW$2,329,00041,005
+100.0%
0.91%
MDVN NewMEDIVATION INC$2,236,00022,450
+100.0%
0.88%
HUM NewHUMANA INC$2,197,00015,298
+100.0%
0.86%
SLXP NewSALIX PHARMACEUTICALS INC$2,195,00019,100
+100.0%
0.86%
ABBV NewABBVIE INC$2,179,00033,301
+100.0%
0.86%
MDAS NewMEDASSETS INC$2,093,000105,900
+100.0%
0.82%
HRC NewHILL ROM HLDGS INC$2,069,00045,350
+100.0%
0.81%
CI NewCIGNA CORPORATION$1,894,00018,400
+100.0%
0.74%
CELG NewCELGENE CORP$1,718,00015,360
+100.0%
0.67%
AET NewAETNA INC NEW$1,701,00019,150
+100.0%
0.67%
RAD NewRITE AID CORP$1,613,000214,500
+100.0%
0.63%
MGLN NewMAGELLAN HEALTH INC$1,550,00025,820
+100.0%
0.61%
SRNE NewSORRENTO THERAPEUTICS INC$1,493,000148,253
+100.0%
0.59%
WBA NewWALGREENS BOOTS ALLIANCE INC$1,387,00018,200
+100.0%
0.54%
ILMN NewILLUMINA INC$1,374,0007,444
+100.0%
0.54%
OCRX NewOCERA THERAPEUTICS INC$1,339,000210,279
+100.0%
0.52%
SYK NewSTRYKER CORP$1,320,00013,994
+100.0%
0.52%
TFX NewTELEFLEX INC$1,286,00011,200
+100.0%
0.50%
VRTX NewVERTEX PHARMACEUTICALS INC$1,283,00010,800
+100.0%
0.50%
WOOF NewVCA INC$1,280,00026,250
+100.0%
0.50%
PFE NewPFIZER INC$1,258,00040,400
+100.0%
0.49%
AMPH NewAMPHASTAR PHARMACEUTICALS IN$1,243,000107,059
+100.0%
0.49%
MTD NewMETTLER TOLEDO INTERNATIONAL$1,240,0004,100
+100.0%
0.49%
NSTG NewNANOSTRING TECHNOLOGIES INC$1,190,00085,404
+100.0%
0.47%
DHR NewDANAHER CORP DEL$1,187,00013,850
+100.0%
0.47%
SSRG NewSYMMETRY SURGICAL INC$1,121,000143,852
+100.0%
0.44%
ZBH NewZIMMER HLDGS INC$1,100,0009,700
+100.0%
0.43%
KND NewKINDRED HEALTHCARE INC$1,067,00058,700
+100.0%
0.42%
ABT NewABBOTT LABS$1,069,00023,750
+100.0%
0.42%
PARNF NewPARNELL PHARMACEUT HLDGS LTD$1,035,000249,427
+100.0%
0.41%
SNY NewSANOFIsponsored adr$967,00021,200
+100.0%
0.38%
AFFX NewAFFYMETRIX INC$961,00097,407
+100.0%
0.38%
ABC NewAMERISOURCEBERGEN CORP$929,00010,300
+100.0%
0.36%
SGMO NewSANGAMO BIOSCIENCES INC$902,00059,300
+100.0%
0.35%
TRNX NewTORNIER N V$864,00033,868
+100.0%
0.34%
ANAC NewANACOR PHARMACEUTICALS INC$839,00026,000
+100.0%
0.33%
HCA NewHCA HOLDINGS INC$780,00010,625
+100.0%
0.31%
QDEL NewQUIDEL CORP$633,00021,902
+100.0%
0.25%
ISRG NewINTUITIVE SURGICAL INC$627,0001,185
+100.0%
0.25%
GILD NewGILEAD SCIENCES INC$622,0006,600
+100.0%
0.24%
HRTX NewHERON THERAPEUTICS INC$584,00058,100
+100.0%
0.23%
JNJ NewJOHNSON & JOHNSON$554,0005,300
+100.0%
0.22%
PBYI NewPUMA BIOTECHNOLOGY INC$549,0002,900
+100.0%
0.22%
LDRH NewLDR HLDG CORP$524,00016,000
+100.0%
0.21%
SPNC NewSPECTRANETICS CORP$517,00014,950
+100.0%
0.20%
CIVI NewCIVITAS SOLUTIONS INC$503,00029,521
+100.0%
0.20%
BLCM NewBELLICUM PHARMACEUTICALS INC$473,00020,547
+100.0%
0.19%
MEIP NewMEI PHARMA INC$470,000110,038
+100.0%
0.18%
DRAD NewDIGIRAD CORP$405,00092,904
+100.0%
0.16%
SIRO NewSIRONA DENTAL SYSTEMS INC$297,0003,400
+100.0%
0.12%
TEAR NewTEARLAB CORP$227,00085,650
+100.0%
0.09%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-02-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LABORATORY CORP AMER HLDGS31Q2 20238.7%
ELEVANCE HEALTH INC29Q3 20238.8%
BECTON DICKINSON & CO28Q2 20239.8%
MCKESSON CORP27Q1 20234.4%
CENCORA INC26Q3 20235.9%
HOLOGIC INC24Q3 20237.5%
JOHNSON & JOHNSON24Q4 20215.5%
ZIMMER HLDGS INC23Q3 20237.5%
BOSTON SCIENTIFIC CORP22Q3 20235.5%
DAVITA INC22Q1 20214.9%

View Endurant Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Endurant Capital Management LP Q4 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AZIYO BIOLOGICS, INC.March 21, 2023576,2534.9%
Oxford Immunotec Global PLCSold outFebruary 17, 202100.0%

View Endurant Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-04-10
13F-HR2024-02-14
13F-HR2023-11-14
SC 13D/A2023-09-08
13F-HR2023-08-14
3/A2023-05-24
13F-HR2023-05-15
32023-05-15
SC 13D2023-05-15
SC 13G/A2023-03-21

View Endurant Capital Management LP's complete filings history.

Compare quarters

Export Endurant Capital Management LP's holdings